| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 27,564,767 | 23,708,037 | 19,230,478 | | Cost of Revenue | 18,967,031 | 15,481,746 | 13,214,043 | | | Gross Profit | 8,597,736 | 8,226,291 | 6,016,435 | | | Operating Expenses | | Research Development | 818,791 | 728,491 | 619,316 | | Selling General and Administrative | 679,238 | 598,793 | 500,761 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 7,099,707 | 6,899,007 | 4,896,358 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| 286,716 | | Earnings Before Interest And Taxes | 7,099,707 | 6,899,007 | 5,183,074 | | Interest Expense | 247,252 | 274,558 | 234,916 | | Income Before Tax | 6,852,455 | 6,624,449 | 4,948,158 | | Income Tax Expense | 1,430,124 | 1,447,933 | 1,189,568 | | Minority Interest | (25,380) |
-
| (48,739) | | | | Net Income From Continuing Ops | 5,396,951 | 5,176,516 | 3,709,851 | | | Non-recurring Events | | Discontinued Operations | 37,850 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 5,434,801 | 5,176,516 | 3,709,851 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,434,801 | $5,176,516 | $3,709,851 |
|
1.48% Nasdaq 
Income Statement
